Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-25-118330
Filing Date
2025-05-13
Accepted
2025-05-13 08:00:27
Documents
19
Period of Report
2025-06-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A d876184ddef14a.htm   iXBRL DEF 14A 557770
3 GRAPHIC g876184g01a02.jpg GRAPHIC 35074
4 GRAPHIC g876184g46l38.jpg GRAPHIC 155061
5 GRAPHIC g876184g48d49.jpg GRAPHIC 178346
6 GRAPHIC g876184g89a01.jpg GRAPHIC 348646
7 GRAPHIC g876184g89a02.jpg GRAPHIC 225355
  Complete submission text file 0001193125-25-118330.txt   3370716

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA caba-20241231.xsd EX-101.SCH 2504
22 EXTRACTED XBRL INSTANCE DOCUMENT d876184ddef14a_htm.xml XML 103405
Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39103 | Film No.: 25937224
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)